ArticleSignal transduction and targeted therapy2021

Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses.

Mirko Cortese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.